EDGAR Filing Documents for 0001213900-20-008240

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001213900-20-008240

Filing Date

2020-03-31

Accepted

2020-03-31 16:45:12

Documents

Period of Report

2019-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO.1 TO FORM 20-F	f20f2019a1_kitovpharma.htm	20-F/A	103742
2	AMENDED AND RESTATED LICENSE EFFECTIVE AS OF THE 25TH DAY OF MAY, 2010 BY AND BE	f20f2019a1ex4-23_kitov.htm	EX-4.23	147080
3	FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT, BY AND BETWEEN TEL HA	f20f2019a1ex4-24_kitov.htm	EX-4.24	13776
4	SECOND AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT, BY AND BETWEEN TEL H	f20f2019a1ex4-25_kitov.htm	EX-4.25	21162
5	ASSIGNMENT AND ASSUMPTION AGREEMENT EFFECTIVE AS OF MARCH 21, 2019, BETWEEN TEL	f20f2019a1ex4-26_kitov.htm	EX-4.26	19318
6	MASTER DEVELOPMENT SERVICES AGREEMENT BETWEEN FAMEWAVE LTD., AND RENTSCHLER BIOP	f20f2019a1ex4-27_kitov.htm	EX-4.27	299639
7	CERTIFICATION	f20f2019a1ex12-1_kitov.htm	EX-12.1	3289
8	CERTIFICATION	f20f2019a1ex12-2_kitov.htm	EX-12.2	3063
9	GRAPHIC	ex4-27_001.jpg	GRAPHIC	13504
	Complete submission text file	0001213900-20-008240.txt		630995

Mailing Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101

Business Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101 97239333121